50 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hypoglycemic Agents"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Hypoglycemic Agents;   Diabetic Blood Glucose Monitoring;   Exercise
Interventions: Drug: MET + Vildagliptin Group;   Drug: MET + Glibenclamide Group
2 Recruiting Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy
Condition: Type 2 Diabetes
Interventions: Other: 1: incretin-based therapy;   Other: 2: other antidiabetic
3 Not yet recruiting Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1;   Hypoglycemia
Interventions: Drug: Exenatide;   Drug: Placebo
4 Unknown  Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Vitamin C;   Drug: glyburide
5 Recruiting Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Alogliptin
6 Not yet recruiting Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2
Conditions: Diabetes Mellitus;   Hypoglycemic Episodes
Interventions: Drug: Metformin;   Drug: Dapagliflozin;   Drug: Metformin up-titration
7 Recruiting Oral Antidiabetic Agents in Pregnancy
Condition: Gestational Diabetes
Interventions: Drug: Metformin;   Drug: Glyburide
8 Recruiting Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Liraglutide;   Drug: Placebo
9 Recruiting A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients
Conditions: Type 1 Diabetes;   Severe Hypoglycemic Unawareness
Intervention: Biological: Islet Cell Transplant
10 Unknown  The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark
Conditions: Type 2 Diabetes;   Hypercholesterolemia
Interventions: Dietary Supplement: Cinnamonforce;   Dietary Supplement: Placebo
11 Unknown  Antidiabetic Effects of Adding a DPP-4 Inhibitor (Sitagliptin) to Pre-Existing Treatment With an Incretin Mimetic (Liraglutide) in Patients With Type 2 Diabetes Treated With Metformin
Condition: Type 2 Diabetes
Interventions: Drug: Sitagliptin;   Drug: Placebo;   Other: Mixed meal test;   Drug: Liraglutide
12 Recruiting Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
Conditions: Prediabetes;   Obesity
Interventions: Drug: Exenatide;   Drug: Saxagliptin;   Drug: Exenatide ER;   Other: Placebo
13 Recruiting Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Ethanol;   Drug: Glucagon
14 Recruiting Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment
Conditions: Breast Cancer;   Bladder Cancer
Intervention:
15 Recruiting Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations
Condition: Diabetes Mellitus
Interventions: Other: Experimental Group instructions for glucose management via App;   Other: Placebo Comparator general instructions
16 Recruiting Acute Kidney Injury in Patients on Dapagliflozin and Other Antidiabetic Medications
Condition: Acute Kidney Injury
Intervention:
17 Recruiting Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea
Condition: Type 2 Diabetes
Intervention: Other: Observational
18 Recruiting Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Placebo;   Drug: Exenatide
19 Unknown  A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Repaglinide
20 Recruiting Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Mellitus Patients Not Achieving Glycemic Targets on Basal Insulin With/Without Anti-Hyperglycemic Agents
Condition: Diabetes Mellitus, Type 2 (T2DM)
Interventions: Device: Bolus Insulin Patch (Calibra Finesse);   Device: Insulin Pen (Novo-Nordisk FlexPen®)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years